Adhesion of Follicular Lymphoma Cells to Lymphoid Germinal Centers—A Potential Mechanism of Tumor Cell Homing Following Autologous Transplantation

References

• Jaffe E.S., Shevach E.M., Frank M.M., Bered C.W., Green I. Nodular lymphoma—evidence for origin from follicular B lymphocytes. N. Engl. J. Med. 1974; 290: 814–819
   Web of Science ®Google Scholar
• Harris N.L., Nadler L.M., Bhan A.K. Im-munologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Am. J. Pathol. 1984; 117: 262–272
   PubMed Web of Science ®Google Scholar
• Stein H., Gerdes J., Mason D.Y. The normal and malignant germinal centre. Clin. Haernatol. 1982; 11: 531–559
   PubMedGoogle Scholar
• Freedman A.S., Munro M.J., Rice G.E., Bevilacqua M.P., Morimoto C., McIntyre B.W., Rhynhart K., Pober J.S., Nadler L.M. Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110. Science 1990; 249: 1030–1033
   PubMed Web of Science ®Google Scholar
• Hemler M.E., Huang C., Takada Y., Schwarz L., Strominger J.L., Clabby M.L. Characterization of the cell surface heterodimer VLA-4 and related peptides. J. Biol. Chem. 1987; 262: 11478–11485
   PubMed Web of Science ®Google Scholar
• Osborn L., Hession C., Tizard R., Vassallo C., Luhows-Kyj S., Chi-Rosso G., Lobb R. Direct expression cloning of vascular cell adhesion molecule I, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59: 1203–1211
   PubMed Web of Science ®Google Scholar
• Rice G.E., Munro J.M., Corless C., Bevilacqua M.P. Vascular and non-vascular expression of INCAM-110. Am. J. Pathol. 1991; 138: 385–393
   PubMed Web of Science ®Google Scholar
• Freedman A., Munro J., Morimoto C., McIntyre B., Rhynhart K., Lee N., Nadler L. Follicular non-Hodgkin's lymphoma cell adhesion to normal and neoplastic germinal centers involves VLA-4 and VCAM-1. Blood 1992; 79: 206–212
   PubMed Web of Science ®Google Scholar
• Portlock C.S. “Good risk” non-Hodgkin's lymphomas: Approaches in management. Semin. Hematol. 1983; 20: 25–34
   PubMed Web of Science ®Google Scholar
• Kosco M.H., Burton G.F., Kapasi Z.F., Szakal A.K., Tew J.G. Antibody-forming cell induction during an early phase of germinal centre development and its delay with ageing. Immunology 1989; 68: 312–318
   PubMed Web of Science ®Google Scholar
• Dilosa R.M., Maeda K., Masuda A., Szakal A.K., Tew J.G. Germinal center B cells and antibody production in the bone marrow. J. Immunol. 1991; 146: 4071–4077
   PubMed Web of Science ®Google Scholar
• Morimoto C., Letvin N.L., Boyd A.W., Hagan M., Brown H.M., Komacki M.M., Schlossman S.F. The isolation and characterization of the human helper inducer T cell subset. J. Immunol. 1985; 134: 3762–3769
   PubMed Web of Science ®Google Scholar
• Stashenko P., Nadler L.M., Hardy R., Schlossman S.F. Characterization of a new B lymphocyte specific antigen in man. J. Zmrnunol. 1980; 125: 1678–1685
   PubMed Web of Science ®Google Scholar
• Griffin J.D., Ritz J., Nadler L.M., Schlossman S.F. Expression of myeloid differentiation antigens on nor mal and malignant myeloid cells. J. Clin. Invest. 1981; 68: 932–941
   PubMed Web of Science ®Google Scholar
• Nadler L.M., Anderson K.C., Marti G., Bates M., Paark E., Daley J.F., Schlossman S.F. B4, a human B cell associated antigen expressed on normal, mitogen ac tivated, and malignant B lymphocytes. J. Immunol. 1983; 131: 244–250
   PubMed Web of Science ®Google Scholar
• Boyd A.W., Anderson K.C., Freedman A.S., Fisher D.C., Slaughenhoupt B.L., Schlossman S.F., Nadler L.M. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional char acterization of the B cell population responding to anti-Ig antibody. J. Immunol. 1985; 134: 1516–1523
   PubMed Web of Science ®Google Scholar
• Hercend T., Griffin J.D., Bensussan A., Schmidt R.E., Edson M.A., Brennan A., Murray C., Daley J.F., Schlossman S.F., Ritz J. Generation of monoclonal antibodies to a human natural killer clone: Character ization of two natural kell cell-associated antigen, NKH1A and NKH2 expressed on subset of large granula lymphocytes. J. Clin. Invest. 1985; 75: 932–943
   PubMed Web of Science ®Google Scholar
• Carlos T.M., Schwartz B.R., Kovach N.L., Yee E., Rosso M., Osbom L., Chi-Rosso G., Newman B., Lobb R., Harlan J.M. Vascular cell adhesion molecure-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 1990; 76: 965–970
   PubMed Web of Science ®Google Scholar
• National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The non-Hodgkin's lymphoma classification project. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Freeman G.J., Freedman A.S., Rabinowe S.N., Segil J.M., Horowitz J., Rosen K., Whitman J.F., Nadler L.M. Interleukin 6 gene expression in normal and neoplastic B cells. J. Clin. Invest. 1989; 83: 1512–1518
   PubMed Web of Science ®Google Scholar
• Minowada J., Janossy G., Greaves M.F., Tsubota T., Srivastava B. I. S., Morikawa S., Tatsumi E. Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines. J. Natl. Cancer Inst. 1978; 60: 1269–1275
   PubMed Web of Science ®Google Scholar
• Koopman G., Parmentier H.K., Schuurman H.-K., New man W., Meijer C. J. L. M., Pals S. Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule I pathways. J. Exp. Med. 1991; 173: 1297–1304
   PubMed Web of Science ®Google Scholar
• Springer T.A. Adhesion receptors of the immune system. Nature 1990; 346: 425–434
   PubMed Web of Science ®Google Scholar
• Anderson T., Chabner B.A., Young R.C., Berard C.W., Garvin A.J., Simon R.M., DeVita V.T. Malignant lymphomas. Cancer 1982; 50: 2699–2707
   PubMed Web of Science ®Google Scholar
• Gribben J., Freedman A., Woo S., Blake K., Shu R. G. F., Longtine J., Pinkus G., Nadler L. All ad vanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and af ter treatment. Blood 1991; 78: 3275–3280
   PubMed Web of Science ®Google Scholar
• Sharp J., Kessinger M., Pirmccello S., Masih A., Mann S., DeBoer J., Sanger W., Weisenburger D. Frequency of detection of suspected lymphoma cells in peripheral stem cell collections. Autologous Bone Marrow Transplanfarion V, K. Dicke, J. Armitage, M. Dicke-Evinger. University of Ne braska Medical Center, Omaha, NE 1991; 801–810
   Google Scholar
• Hardingham J., Kotasek D., Sage R., Dobrovic A., Gooley T., Dale B. Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation. Bone Marrow Transplant 1993; 11: 15–20
   PubMed Web of Science ®Google Scholar
• Glorieux P., Bouffet E., Philip I., Biron P., Holzapfel L., Floret D., Bouvier R., Vitrey D., Pinkerton R., Brunat M.M., et al. Metastatic interstitial pneumonitis after autologous bone marrow transplantation. A consequence of reinjection of malignant cells?. Cancer 1986; 58: 2136–2139
   PubMed Web of Science ®Google Scholar
• Vaughan W.P., Weisenburger D.D., Sanger W., Gale R.P., Armitage I.O. Early leukemic recurrence of non-Hodgkin lymphoma after high-dose anti-neoplastic therapy with autologous marrow rescue. Bone Marrow Truns plant. 1987; 1: 373–378
   PubMed Web of Science ®Google Scholar
• Gribben J.G., Freedman A.S., Neuberg D., Roy D.C., Blake K.W., Woo S.D., Grossbard M.L., Rabinowe S.N., Coral F., Freeman G.J., Ritz J., Nadler L.M. Immunologic purging of marrow assessed by PCR be fore autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med. 1991; 325: 1525–1533
   PubMed Web of Science ®Google Scholar
• Freedman A.S., Ritz J., Neuberg D., Anderson K.C., Rabinowe S.N., Mauch P., Takvorian T., Soiffer R., Blake K., Yeap B., Coral F., Helfin L., Nadler L.M. Autologous bone marrow transplantation in 69 patients with a history of low grade B cell non-Hodgkin's lymphoma. Blood 1991; 77: 2524–2529
   PubMed Web of Science ®Google Scholar